US 10006025
Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
granted A61PA61P1/16A61P31/00
Quick answer
US patent 10006025 (Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P1/16, A61P31/00